NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
Public ClinicalTrials.gov record NCT01835548. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double-Blind, Placebo Controlled, Parallel Group Study of NT0102 in Children (Ages 6 12 Years) With Attention-Deficit Hyperactivity Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, placebo-controlled, parallel group, Phase 3 trial to evaluate the safety and efficacy of NT0102 in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 12 years of age in a laboratory classroom study.
Study identification
- NCT ID
- NCT01835548
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 87 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 6 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2013
- Primary completion
- Jun 30, 2014
- Completion
- Jun 30, 2014
- Last update posted
- Jan 16, 2018
2013 – 2014
United States locations
- U.S. sites
- 4
- U.S. states
- 3
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Florida Clinical Research Center | Bradenton | Florida | 34208 | — |
| Florida Clinical Research Center | Maitland | Florida | 32751 | — |
| Center for Psychiatry and Behavioral Medicine | Las Vegas | Nevada | 89128 | — |
| Duke University | Durham | North Carolina | 27705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Attention Deficit Hyperactivity Disorder (ADHD) trials
Other public records listing Attention Deficit Hyperactivity Disorder (ADHD). Sorted by last update posted; newest first. Not a recommendation.
- NCT07793045: Binaural Beats Stimulation for Adults With ADHD Recruiting
- NCT07654205: Smartphone-based Intervention for Young Adults With ADHD Recruiting
- NCT07226219: Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease Recruiting
- NCT06810180: Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Heterogeneity in ADHD Recruiting
- NCT06853665: The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine Recruiting
- NCT06960980: Improving ADHD Teen Driving - Virtual Reality Recruiting
All Attention Deficit Hyperactivity Disorder (ADHD) trials →
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01835548, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 16, 2018 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01835548 live on ClinicalTrials.gov.